Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes

NCT04342260 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2025-02-20

Study results available
· View outcomes & findings →

Summary

This study is designed to test if patient-reported outcomes with automated reporting to clinicians for remote monitoring of postoperative symptoms is feasible and improves quality of life, health outcomes, and service utilization in thoracic surgery patients. Patients undergoing thoracic surgery will be asked to self-report symptoms for remote monitoring by their care team.

Conditions

  • Thoracic Surgery

Interventions

OTHER

Active Monitoring

The participants randomized to active symptom monitoring will have alerts sent to their clinicians when their PRO symptom scores exceed baseline postoperative scores (when discharge day scores are available) by 2 points or more, or when 'severe' or 'very severe' symptoms are reported.

OTHER

Passive Monitoring

Participants randomized to the passive PRO monitoring arm will complete the same PROs as participants in the active monitoring arm, but will not have alerts sent to their clinician.

Sponsors & Collaborators

  • Thoracic Surgery Foundation

    collaborator UNKNOWN
  • American College of Surgeons

    collaborator OTHER
  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Gita Mody, MD, MPH · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2023-11-10
Completion
2023-11-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04342260 on ClinicalTrials.gov